Results
Mean baseline BNP was significantly higher in VR (304.01 vs 105.8 pg/ml, p < 0.001), although baseline LVEF (54.4% vs 52.5%) was similar in both. Pre-operative Tn-I and CK-MB levels were higher in those undergoing OPCABG. Biomarker release kinetics were significantly different amongst two groups. All three biomarkers increased rapidly within 6 hours of OPCABG. In VR group, BNP levels initially decreased (within 6 hours), and then peaked at 24 hours; in contrast Tn-I and CKMB levels increased within 6 hours, with declining trends at 24 hours. Peak BNP levels occurred usually by 24-48 hours. At 1 month, levels of all biomarkers were similar to baseline.
In patients undergoing OPCABG, those with higher baseline BNP had lower LVEF; while in patients undergoing VR, those with higher baseline BNP levels had higher prevalence of atrial fibrillation and higher RV systolic pressure. Patients with higher pre-operative BNP had longer post-operative inotrope duration and ventilator time. In patients undergoing VR, patients with higher baseline BNP also had longer post-operative ICU and hospital stay. In both groups, baseline, post-operative and delta BNP levels were significant predictors of post-operative inotrope duration and ventilation time.
Discussion/Conclusion
Patients of RHD undergoing VR had higher baseline BNP levels as compared to those undergoing OPCABG, despite similar LVEF. Release kinetics of biomarkers following OPCABG and valve surgery are significantly different from each other. Of all studied biomarkers, only BNP predicted post-operative inotrope duration and ventilation times. Agarwal et al. Journal of Cardiothoracic Surgery 2015, 10(Suppl 1):A208 http://www.cardiothoracicsurgery.org/content/10/S1/A208
